Bo Ahrén

111 – 120 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
11
12
13
14
…
40
next »

2013
Mark Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
Alba, M. ; Ahrén, Bo ^LU ; Inzucchi, S. E. ; Guan, Y. ; Mallick, M. ; Xu, L. ; O'Neill, E. A. ; Williams-Herman, D. E. ; Kaufman, K. D. and Goldstein, B. J. (2013) In Diabetes, Obesity and Metabolism 15(12). p.1101-1110
- Contribution to journal › Article
Mark Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
Ahrén, Bo ^LU (2013) In Vascular Health and Risk Management 9. p.155-163
- Contribution to journal › Article
Mark Methods and Models for Metabolic Assessment in Mice
Pacini, G. ; Omar, Bilal ^LU and Ahrén, Bo ^LU (2013) In Journal of Diabetes Research
- Contribution to journal › Article
Mark Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
Ohlsson, Lena ^LU ; Alsalim, Wathik ^LU ; Carr, Richard D ; Tura, Andrea ; Pacini, Giovanni ; Mari, Andrea and Ahrén, Bo ^LU (2013) In Diabetes, Obesity and Metabolism 15(6). p.531-537
- Contribution to journal › Article
Mark Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M).
Ahrén, Bo ^LU ; Leguizamo Dimas, Aniceto ; Miossec, Patrick ; Saubadu, Stéphane and Aronson, Ronnie (2013) In Diabetes Care 36(9). p.2543-2550
- Contribution to journal › Article
Mark Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
Omar, Bilal ^LU ; Vikman, Jenny ^LU ; Sörhede Winzell, Maria ^LU ; Voss, Ulrikke ^LU ; Ekblad, Eva ^LU ; Foley, J E and Ahrén, Bo ^LU (2013) In Diabetologia 56(8). p.1752-1760
- Contribution to journal › Article
Mark Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
Johansson, Per ^LU ; Åberg, D. ; Johansson, J-O ; Mattsson, N. ; Hansson, Oskar ^LU ; Ahrén, Bo ^LU ; Isgaard, J. ; Åberg, N. ; Blennow, K. and Zetterberg, H. , et al. (2013) Endokrindagarna, 2013
- Contribution to conference › Poster
2012
Mark Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU ; Schweizer, Anja ; Foley, James E and Ahrén, Bo ^LU (2012) In The Journal of clinical endocrinology and metabolism 97(10). p.3799-3806
- Contribution to journal › Article
Mark Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models
Omar, Bilal ^LU ; Pacini, Giovanni and Ahrén, Bo ^LU (2012) In Nutrients 4(10). p.1367-1381
- Contribution to journal › Article
Mark Varning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
Agardh, Carl-David ^LU ; Ahrén, Bo ^LU ; Hanås, Ragnar ; Jansson, Stefan ; Smith, Ulf ; Toft, Eva and Ostenson, Claes-Göran (2012) In Läkartidningen 109(25). p.1208-1209
- Contribution to journal › Article

« previous
1
…
11
12
13
14
…
40
next »